Long-Term Safety Of PF-00547659 In Ulcerative Colitis

Completed · Phase 2

Conditions studied: Ulcerative Colitis

In brief

Subjects with Ulcerative Colitis who have completed an induction study with PF-00547659 will receive an additional 144 weeks of open-label treatment to evaluate the long-term safety of the drug.

Key facts

Study ID
NCT01771809
Run by
Shire
People needed
330
Starts
2013-03-18
Expected to finish
2017-12-13
Last updated by the study team
2021-06-03

Who can join

Age: 18 and older, up to 66. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.